Immuno-Biological Laboratories Co (TSE:4570) EV-to-FCF: (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4570 Immuno-Biological Laboratories Co Ltd TSE:4570
52 GF Score
Price 円1,088.00
GF Value 円588.98
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Immuno-Biological Laboratories Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Immuno-Biological Laboratories Co's Enterprise Value is 円9,397 Mil. Immuno-Biological Laboratories Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil. Therefore, Immuno-Biological Laboratories Co's EV-to-FCF for today is .

The historical rank and industry rank for Immuno-Biological Laboratories Co's EV-to-FCF or its related term are showing as below:

TSE:4570' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 34.83
Current: 34.83

During the past 13 years, the highest EV-to-FCF of Immuno-Biological Laboratories Co was 34.83. The lowest was 0.00. And the median was 0.00.

TSE:4570's EV-to-FCF is ranked worse than
70.4% of 321 companies
in the Biotechnology industry
Industry Median: 18.01 vs TSE:4570: 34.83

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-28), Immuno-Biological Laboratories Co's stock price is 円1088.00. Immuno-Biological Laboratories Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円39.547. Therefore, Immuno-Biological Laboratories Co's PE Ratio (TTM) for today is 27.51.

Immuno-Biological Laboratories Co  (TSE:4570) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Immuno-Biological Laboratories Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1088.00/39.547
=27.51

Immuno-Biological Laboratories Co's share price for today is 円1088.00.
Immuno-Biological Laboratories Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円39.547.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Immuno-Biological Laboratories Co EV-to-FCF Related Terms

Immuno-Biological Laboratories Co EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Immuno-Biological Laboratories Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immuno-Biological Laboratories Co EV-to-FCF Chart

Immuno-Biological Laboratories Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.73 128.93 38.55 31.08 43.66

Immuno-Biological Laboratories Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 43.66 0.00

TSE:4570 vs VRTX, REGN, RVMD: EV-to-FCF Comparison

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immuno-Biological Laboratories Co EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's EV-to-FCF falls into.


TSE:4570
52GF Score
Immuno-Biological Laboratories Co Ltd TSE:4570
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immuno-Biological Laboratories Co EV-to-FCF Calculation

Immuno-Biological Laboratories Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=9396.913/0
=

Immuno-Biological Laboratories Co's current Enterprise Value is 円9,397 Mil.
Immuno-Biological Laboratories Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Immuno-Biological Laboratories Co (TSE:4570) Overvalued in 2026?

Based on GuruFocus' analysis, Immuno-Biological Laboratories Co stock appears to be overvalued. The current stock price of 円1,088.00 is trading 84.7% above its estimated GF Value™ of 円588.98. GuruFocus considers Immuno-Biological Laboratories Co to be Significantly Overvalued.

Key valuation signals for TSE:4570:

  • EV-to-FCF:
  • GF Value™: 円588.98 vs. price of 円1,088.00 (84.7% above fair value)
  • GF Score™: 52/100 with 2 warning signs

No single metric tells the full story. See the TSE:4570 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Immuno-Biological Laboratories Co Business Description

Address 1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.
52GF Score

Get the complete analysis for TSE:4570

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,088.00
Price
円588.98
GF Value